Clinical chemical analyzers and reagents
Ended Awarded Last action
- Contract number
- HT940622F0039
- Awardee
-
Roche Diagnostics Corporation UEI JDMDFEZBYH36
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $870,113
Award facts
- Opportunity
-
- HT940622R0006 Solicitation number
- Contract value 100% obligated
- $870,113.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Jacksonville, FL 32214, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $217,528 | |
| Funding Only Action | $217,528 | |
| Exercise an Option | $0 | |
| Other Administrative Action | $0 | |
| Original award | $435,057 |
About this award
This is a firm fixed price delivery order contract awarded by the Defense Health Agency to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract, valued at $870,113.40, is for the provision of clinical chemical analyzers and reagents. The contract has no set-aside designation, indicating it was competed openly. Roche Diagnostics Corporation holds multiple significant Indefinite Delivery Contracts (IDCs) and Blanket Purchase Agreements (BPAs) across federal agencies, including a $37 million BPA with the Defense Health Agency for immunochemistry and clinical chemistry testing, and several Veterans Affairs-specific IDCs. Many of these contracts are established under General Services Administration (GSA) Schedule contracts, specifically the Critical Analyzers, Laboratory (FSS-66-III) and In Vitro Diagnostics, Reagents, Test (FSS-65-VII) schedules, enabling federal agencies to efficiently acquire Roche's medical diagnostic technologies through pre-negotiated pricing and terms.
Quick answers
Who was awarded contract HT940622F0039?
HT940622F0039 was awarded to Roche Diagnostics Corporation by Defense Health Agency (Department of Defense) on July 1, 2022.
How much is contract HT940622F0039 worth?
The government has obligated $870,113 on HT940622F0039.
Is contract HT940622F0039 an order under another contract?
Yes. HT940622F0039 is a delivery order under V797P7347A, a federal supply schedule, on Critical Analyzers, Laboratory (FSS-66-III).
Was contract HT940622F0039 competed?
The extent of competition for HT940622F0039 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award